{
    "project_id": "170965",
    "broad_study_type": "other",
    "narrow_study_type": "diagnostic_tool_development",
    "trial_phase": "N/A",
    "observational_timeframe": "N/A",
    "justification": "develop novel MRI techniques that are more powerful to detect very subtle brain lesions",
    "data_type": "canadian",
    "ipd_used": "individual",
    "novelty_statement": "The advanced methods we propose have the potential to make the surgical treatment available to many more patients with severe epilepsy and improve our understanding of the cause of epilepsy.",
    "replication_study": "no",
    "target_population_size": "N/A",
    "age_range": "adults",
    "gender_focus": "mixed",
    "vulnerable_populations": "yes",
    "rare_disease": "no",
    "population_description": "patients with medically intractable temporal lobe epilepsy",
    "intervention_category": "diagnostic",
    "intervention_name": "high field magnetic resonance imaging",
    "control_type": "no_control",
    "dose_response": "no",
    "combination_therapy": "no",
    "personalized_medicine": "yes",
    "primary_outcome": "detection of subtle brain lesions",
    "primary_outcome_type": "diagnostic",
    "safety_focus": "no",
    "quality_of_life": "no",
    "biomarker_endpoints": "yes",
    "time_to_event": "no",
    "composite_endpoint": "no",
    "ai_machine_learning": "no",
    "digital_health": "yes",
    "telemedicine": "no",
    "wearable_technology": "no",
    "big_data_analytics": "yes",
    "blockchain": "no",
    "cost_effectiveness": "no",
    "budget_impact": "no",
    "health_technology_assessment": "yes",
    "resource_utilization": "no",
    "productivity_outcomes": "no",
    "implementation_science": "no",
    "policy_evaluation": "no",
    "health_system_integration": "no",
    "scalability_assessment": "no",
    "barrier_identification": "no",
    "adaptive_design": "no",
    "bayesian_methods": "no",
    "machine_learning_analysis": "yes",
    "novel_biostatistics": "yes",
    "patient_reported_outcomes": "no",
    "real_world_evidence": "no",
    "industry_partnership": "no",
    "patient_engagement": "yes",
    "community_based": "no",
    "indigenous_collaboration": "no",
    "international_collaboration": "no",
    "international_network": "no",
    "regulatory_pathway": "no",
    "ethics_focus": "no",
    "consent_innovation": "no",
    "data_sharing": "no",
    "therapeutic_area": "neurology",
    "disease_stage": "chronic",
    "comorbidity_focus": "no",
    "pandemic_related": "no",
    "environmental_health": "no",
    "social_determinants": "no",
    "health_equity": "no",
    "climate_health": "no",
    "urban_rural": "unclear",
    "biobank_use": "no",
    "registry_linkage": "no",
    "cohort_establishment": "no",
    "platform_trial": "no",
    "study_duration": "medium_term",
    "multicenter": "no",
    "healthcare_setting": "hospital",
    "disease_area": "epilepsy",
    "methodology_innovation": "developing high-field MRI techniques for improved lesion detection in temporal lobe epilepsy",
    "knowledge_translation_focus": "yes",
    "equity_considerations": "no"
} 